"team appointed to conduct clinical trials of its insomnia products using Blake’s proprietary Zleepax™ formula"
This looks like a typical reversal play after a huge run up. The news from March 2 introduces the team behind the clinical study. There is a huge market for this. Could be a nice reversal play here.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.